CERTICAN

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom

Active ingredients

The drug CERTICAN contains one active pharmaceutical ingredient (API):

1 Everolimus UNII 9HW64Q8G6G - EVEROLIMUS

Everolimus is a selective mTOR (mammalian target of rapamycin) inhibitor. mTOR is a key serine-threonine kinase, the activity of which is known to be upregulated in a number of human cancers. Read about Everolimus

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AH02	Everolimus	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors
Discover more medicines within L04AH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5737Y, 5738B, 5739C, 5740D, 6459Y, 6460B, 6461C, 8840G, 8841H, 8842J, 9352F, 9582H
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526525103118214, 526525104114212, 526525105110210
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.978-10-04, 25.979-10-04
Country: EE	Ravimiamet	Identifier(s): 1155901, 1155912, 1155923, 1155934, 1156047, 1156058, 1156069, 1156070, 1156081, 1156092, 1156104, 1156115, 1156126, 1156137, 1156148, 1156159, 1156160, 1156171, 1156182, 1156193, 1156205, 1156216, 1156227, 1156238
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 66001, 66002, 66006, 66007, 66008, 66009
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 014853, 014859, 014917
Country: FR	Base de données publique des médicaments	Identifier(s): 60298932, 60658711, 62507754, 62654074, 63177804, 64299095
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 296993, 296995
Country: HK	Department of Health Drug Office	Identifier(s): 54331, 54333, 54334, 54335
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-592546271, HR-H-809985014
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4840, 4841, 4842
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999022F1028, 3999022F2024, 3999022F3020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1016726, 1016727, 1016728, 1016729, 1016730, 1016731, 1016732, 1016733, 1016734, 1016735, 1016736, 1016737, 1016738, 1016739, 1016740, 1016741, 1016742, 1016743, 1021787, 1021788, 1021789, 1021790, 1021791, 1021792
Country: MT	Medicines Authority	Identifier(s): MA1249/00401, MA1249/00403
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 266M2003
Country: NG	Registered Drug Product Database	Identifier(s): A4-4290, A4-4292
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 75078, 75086, 75094
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11346, 11347, 11348, 11349, 11350, 11351
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100132260, 100132320, 100132508, 100328571, 100328588, 100328594
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W42568001, W42568002, W42568003, W42568004, W42569001, W42569002, W42569003, W42569004, W42570001, W42570002, W42570003, W42570004, W42572001, W42572002, W42572003, W42572004
Country: SG	Health Sciences Authority	Identifier(s): 13193P, 13194P, 13195P, 13196P, 13197P, 13198P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10283431H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504011302, 8699504011357, 8699504070002